Rhonda Farnum - Jan 21, 2025 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol
TBPH
Transactions as of
Jan 21, 2025
Transactions value $
-$36,000
Form type
4
Date filed
1/23/2025, 06:05 PM
Previous filing
Nov 22, 2024
Next filing
Feb 24, 2025

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Remarks:

This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 03/14/2024.